 | Up a level |
Glaus, J; Vandeleur, C; Gholam-Rezaee, M; Castelao, E; Perrin, M; Rothen, S; Bovet, P; Marques-Vidal, P; von Känel, R; Merikangas, K; Mooser, V; Waterworth, D M; Waeber, G; Vollenweider, P; Preisig, M (2012). Atypical depression and alcohol misuse are related to the cardiovascular risk in the general population. Acta psychiatrica Scandinavica, 128(4), pp. 282-293. Oxford: Wiley-Blackwell
Perrin, M; Ramelet, A A (2011). Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions. European journal of vascular and endovascular surgery EJVES, 41(1), pp. 117-25. London: Elsevier 10.1016/j.ejvs.2010.09.025
Rivier, J; Gulyas, J; Erchegyi, J; Koerber, SC; Grace, C; Riek, R; DiGruccio, M; Perrin, M; Rivier, C; Eltschinger, V; Waser, B; Cescato, R; Reubi, J.C.; Vale, W (2006). Guiding principles applied in the design of GPCR-selective hypothalamic hormone agonists and antagonists. In: Insights into Receptor Function and New Drug Development Targets (pp. 117-138). Heidelberg: Springer Verlag 10.1007/3-540-34447-0_8
